-4.53% to Target, Mizuho Securities Reaffirms “Hold” Rating for Mastercard (MA) Stock; Creative Planning Cut Its Bluebird Bio (BLUE) Stake

October 12, 2017 - By Migdalia James

Creative Planning decreased Bluebird Bio Inc (BLUE) stake by 98.51% reported in 2017Q2 SEC filing. Creative Planning sold 47,231 shares as Bluebird Bio Inc (BLUE)’s stock rose 6.94%. The Creative Planning holds 714 shares with $75,000 value, down from 47,945 last quarter. Bluebird Bio Inc now has $5.95 billion valuation. The stock rose 3.99% or $5 reaching $130.45. About 681,075 shares traded. bluebird bio Inc (NASDAQ:BLUE) has risen 112.34% since October 12, 2016 and is uptrending. It has outperformed by 95.64% the S&P500.

Among 30 analysts covering Mastercard Incorporated (NYSE:MA), 26 have Buy rating, 0 Sell and 4 Hold. Therefore 87% are positive. Mastercard Incorporated has $165.0 highest and $35 lowest target. $133.08’s average target is -9.25% below currents $146.65 stock price. Mastercard Incorporated had 69 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets downgraded Mastercard Inc (NYSE:MA) rating on Thursday, January 5. RBC Capital Markets has “Outperform” rating and $130 target. The firm earned “Top Pick” rating on Friday, June 16 by RBC Capital Markets. The stock has “Buy” rating by Piper Jaffray on Thursday, September 7. Stifel Nicolaus maintained it with “Buy” rating and $116 target in Monday, October 31 report. Cowen & Co initiated Mastercard Inc (NYSE:MA) rating on Wednesday, September 30. Cowen & Co has “Outperform” rating and $110 target. The firm has “Overweight” rating by Barclays Capital given on Friday, September 8. The firm has “Hold” rating given on Thursday, July 27 by Credit Suisse. The company was maintained on Thursday, July 27 by Piper Jaffray. The stock of Mastercard Inc (NYSE:MA) has “Buy” rating given on Thursday, October 8 by Guggenheim. The firm has “Buy” rating given on Thursday, September 28 by Cantor Fitzgerald.




Investors sentiment increased to 1.68 in 2017 Q2. Its up 0.68, from 1 in 2017Q1. It is positive, as 21 investors sold BLUE shares while 53 reduced holdings. 50 funds opened positions while 74 raised stakes. 47.91 million shares or 5.30% more from 45.50 million shares in 2017Q1 were reported. 257,829 were reported by Deutsche National Bank & Trust Ag. Peregrine Asset Advisers owns 8,390 shares. Commerzbank Aktiengesellschaft Fi owns 0.01% invested in bluebird bio Inc (NASDAQ:BLUE) for 5,565 shares. Goldman Sachs Gru has 0.01% invested in bluebird bio Inc (NASDAQ:BLUE) for 485,912 shares. Federated Investors Pa holds 0.01% or 17,854 shares. Qs Invsts Limited Com owns 1,207 shares for 0% of their portfolio. Smith Asset Mgmt Group Lp reported 3,420 shares. Bnp Paribas Arbitrage Sa stated it has 0% of its portfolio in bluebird bio Inc (NASDAQ:BLUE). Natixis Asset accumulated 2,764 shares. Great West Life Assurance Comm Can stated it has 4,509 shares or 0% of all its holdings. First Trust Limited Partnership holds 22,491 shares. Clough Partners Ltd Partnership reported 2,000 shares. Moreover, Benjamin F Edwards has 0% invested in bluebird bio Inc (NASDAQ:BLUE) for 44 shares. Tiverton Asset Mngmt Llc reported 29,178 shares or 0.17% of all its holdings. Profund Ltd Limited Liability Company has 16,681 shares for 0.08% of their portfolio.

Among 22 analysts covering bluebird bio (NASDAQ:BLUE), 12 have Buy rating, 3 Sell and 7 Hold. Therefore 55% are positive. bluebird bio had 58 analyst reports since August 11, 2015 according to SRatingsIntel. Leerink Swann maintained bluebird bio Inc (NASDAQ:BLUE) on Friday, October 14 with “Outperform” rating. TH Capital maintained the stock with “Buy” rating in Thursday, November 5 report. The firm has “Reduce” rating given on Friday, June 16 by Standpoint Research. The rating was downgraded by Jefferies on Wednesday, October 11 to “Hold”. The firm earned “Buy” rating on Friday, October 23 by Jefferies. On Monday, February 27 the stock rating was downgraded by Maxim Group to “Hold”. Morgan Stanley downgraded bluebird bio Inc (NASDAQ:BLUE) on Monday, October 2 to “Underweight” rating. The rating was downgraded by Cantor Fitzgerald to “Sell” on Friday, October 14. TH Capital initiated bluebird bio Inc (NASDAQ:BLUE) rating on Thursday, December 3. TH Capital has “Buy” rating and $121 target. The stock of bluebird bio Inc (NASDAQ:BLUE) has “Buy” rating given on Friday, August 28 by Roth Capital.

Creative Planning increased Gilead Sciences Inc (NASDAQ:GILD) stake by 247,999 shares to 251,999 valued at $17.84 million in 2017Q2. It also upped United Rentals Inc (NYSE:URI) stake by 7,055 shares and now owns 7,655 shares. Ishares Tr (IEZ) was raised too.

Analysts await bluebird bio Inc (NASDAQ:BLUE) to report earnings on November, 1. They expect $-1.59 earnings per share, up 23.19% or $0.48 from last year’s $-2.07 per share. After $-1.73 actual earnings per share reported by bluebird bio Inc for the previous quarter, Wall Street now forecasts -8.09% EPS growth.

Since May 3, 2017, it had 0 insider purchases, and 1 insider sale for $18.97 million activity. 161,742 Mastercard Inc (NYSE:MA) shares with value of $18.97M were sold by BANGA AJAY.

Analysts await Mastercard Inc (NYSE:MA) to report earnings on October, 27. They expect $1.22 earnings per share, up 12.96% or $0.14 from last year’s $1.08 per share. MA’s profit will be $1.30B for 30.05 P/E if the $1.22 EPS becomes a reality. After $1.10 actual earnings per share reported by Mastercard Inc for the previous quarter, Wall Street now forecasts 10.91% EPS growth.

Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.06, from 0.94 in 2017Q1. It turned negative, as 48 investors sold Mastercard Inc shares while 480 reduced holdings. 108 funds opened positions while 357 raised stakes. 790.40 million shares or 0.23% less from 792.22 million shares in 2017Q1 were reported. Skylands Capital Llc has invested 0.03% in Mastercard Inc (NYSE:MA). Rathbone Brothers Pcl reported 1.49% of its portfolio in Mastercard Inc (NYSE:MA). Denver Investment Advsr Llc has invested 0.01% in Mastercard Inc (NYSE:MA). Icon Advisers Inc holds 0.97% of its portfolio in Mastercard Inc (NYSE:MA) for 115,100 shares. Asset Management One Limited reported 1.55 million shares. Suncoast Equity Mngmt stated it has 3.86% of its portfolio in Mastercard Inc (NYSE:MA). Veritas Mgmt (Uk) stated it has 5.92% of its portfolio in Mastercard Inc (NYSE:MA). West Oak Lc holds 0% or 4,015 shares in its portfolio. Arrowmark Colorado Limited Company stated it has 5,228 shares. Pax World Mgmt Ltd Llc reported 0.05% stake. Waratah Capital Advisors Ltd invested in 10,515 shares. Invesco reported 0.19% stake. Ftb Advsrs Inc holds 0.01% in Mastercard Inc (NYSE:MA) or 717 shares. 585,756 are owned by Retirement Of Alabama. Moreover, Retail Bank Pictet Cie (Asia) Limited has 0.99% invested in Mastercard Inc (NYSE:MA) for 17,160 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: